Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...
Odyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners To Acquire ProPharma Group: Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company")...
Linden Agrees to Sell ProPharma Group to Odyssey Investment Partners
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on the healthcare sector, announced an agreement to sell ProPharma Group (the “Company”) to Odyssey...
ProPharma Group Announces Acquisition of Southwood Research
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Southwood Research. Based in Buckinghamshire, United Kingdom, Southwood Research is a leading provider of...
ProPharma Group Acquires The Weinberg Group
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...
ProPharma Group Announces Acquisition of SOLUTIONS in Health
ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of SOLUTIONS in Health Inc., a Canada-based provider of medical information services to the pharmaceutical,...
ProPharma Group Announces New Medical Information Contact Center
ProPharma Group today announces the opening of a new medical information contact center in Fort Washington, Pennsylvania to accommodate our growing business. ProPharma Group, a provider of...
ProPharma Group Announces Acquisition of Xendo
ProPharma Group Announces Acquisition of Xendo: ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Xendo Holding B.V. (“Xendo”), a Netherlands-based...
ProPharma Group Announces New President / CEO
ProPharma Group announced today that Dawn Sherman has been named President and CEO, effective May 14, 2018. A veteran in leading healthcare-focused businesses, Dawn brings extensive international...
